Follow the JW신약 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, JW신약 has published 24 insider filings. Market capitalisation: €94.5bn. The latest transaction was filed on 5 March 2026 (Other). Among the most active insiders: JW홀딩스. The full history is accessible without an account.
24
Insider Decl.
n/a
Thresholds
n/a
19 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 1,020 of 29,063 companies
81.1
score / 100
Value
82
Quality
80
FCF yld4.7%
Earn yld17%
EV/EBITDA5.9x
ROE·
Gross mgn50%
Net mgn19%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
JW신약 es una empresa del sector sanitario y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo de fármacos y soluciones terapéuticas innovadoras.